⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL914298 | 0.97 | — | — | |
| SCHEMBL565381 | 0.83 | USP2 (0.43) | — | |
| SCHEMBL564550 | 0.78 | TSHR (0.52) | — | |
| SCHEMBL563993 | 0.78 | TSHR (0.60) | — | |
| SCHEMBL2065150 | 0.78 | — | — | |
| SCHEMBL7105445 | 0.78 | CA1 (0.33) | — | |
| SCHEMBL5474235 | 0.76 | — | — | |
| SCHEMBL3490136 | 0.76 | USP2 (0.38) | — | |
| Hydrochloric Acid SCHEMBL6934751 | 0.76 | — | — | |
| SCHEMBL5838756 | 0.76 | TSHR (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130203715-A1 | USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS | PULMATRIX, INC. (US) | 2013-08-08 | — | — | US | claimed |
| WO-2012012498-A9 | USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS | PULMATRIX, INC. (US) | 2012-04-05 | — | — | WO | claimed |
| WO-2012012498-A2 | USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS | PULMATRIX, INC. (US) | 2012-01-26 | — | — | WO | claimed |
| US-12473594-B2 | Chemical tagging-based method for modified nucleoside sequencing, enrichment, and measurement | PEKING UNIVERSITY (CN) | 2025-11-18 | — | — | US | disclosed |
| US-20250251361-A1 | SENSING COMPOSITIONS, METHODS, AND DEVICES FOR THE DETECTION OF MOLECULES USING A NANOPORE DEVICE | OXFORD NANOPORE TECH PLC (GB) | 2025-08-07 | — | — | US | disclosed |
| US-12188899-B2 | Sensing compositions, methods, and devices for the detection of molecules using a nanopore device | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-01-07 | — | — | US | disclosed |
| US-20240156728-A1 | MONOVALENT METAL CATION DRY POWDERS FOR INHALATION | PULMATRIX OPERATING CO INC (US) | 2024-05-16 | — | — | US | disclosed |
| US-20230332219-A1 | CHEMICAL TAGGING-BASED METHOD FOR MODIFIED NUCLEOSIDE SEQUENCING, ENRICHMENT, AND MEASUREMENT | PEKING UNIVERSITY (CN) | 2023-10-19 | — | — | US | disclosed |
| WO-2023180953-A1 | INHIBITORS OF HUMAN SLC7A3 FOR THE TREATMENT OF ENDOMETRIOSIS OR UTERINE FIBROIDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GB) | 2023-09-28 | — | — | WO | disclosed |
| CN-107096014-B | Monovalent metal cation dry powder for inhalation | 普马特里克斯营业公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-112176043-B | Sequencing, enrichment and detection method of modified nucleoside based on chemical marker | 北京大学 | 2022-07-12 | — | — | CN | disclosed |
| EP-1490028-A1 | DELIVERY OF A SUBSTANCE TO A PRE-DETERMINED SITE | Applied NanoSystems B.V. (NL) | 2004-12-29 | — | — | EP | disclosed |
| WO-2004060967-A1 | METHODS FOR THE FORMATION OF HYDROGELS USING THIOSULFONATE COMPOSITIONS AND USES THEREOF | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2004-07-22 | — | — | WO | disclosed |
| EP-1397123-A2 | DELIVERY OF SMALL HYDROPHILIC MOLECULES PACKAGED INTO LIPID VESICLES | Applied NanoSystems B.V. (NL) | 2004-03-17 | — | — | EP | disclosed |
| WO-2003084508-A1 | DELIVERY OF A SUBSTANCE TO A PRE-DETERMINED SITE | APPLIED NANOSYSTEMS B.V. (NL) | 2003-10-16 | — | — | WO | disclosed |
| US-20030118636-A1 | Delivery of small hydrophilic molecules packaged into lipid vesicles | APPLIED NANOSYSTEMS B.V. (NL) | 2003-06-26 | — | — | US | disclosed |
| WO-2003025218-A2 | METHODS AND YEAST STRAINS FOR SCREENING ANTIFUNGAL AGENTS | K.U.LEUVEN RESEARCH & DEVELOPMENT (BE) | 2003-03-27 | — | — | WO | disclosed |
| WO-2003000233-A2 | DELIVERY OF SMALL HYDROPHILIC MOLECULES PACKAGED INTO LIPID VESICLES | APPLIED NANOSYSTEMS B.V. (NL) | 2003-01-03 | — | — | WO | disclosed |
| US-20020128203-A1 | Methods of identifying inhibitory compounds and uses thereof | UNIVERSITE DE LAUSANNE (CH) | 2002-09-12 | — | — | US | disclosed |
| WO-2002024177-A2 | METHODS OF IDENTIFYING INHIBITORY COMPOUNDS AND USES THEREOF | UNIVERSITY OF LAUSANNE (CH) | 2002-03-28 | — | — | WO | disclosed |